Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2024-04-15 | Intervacc | Notice of Annual General Meeting in Intervacc AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-15 | Intervacc | Kallelse till årsstämma i Intervacc AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-10 | Intervacc | Intervacc publishes the 2023 Annual Report | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-10 | Intervacc | Intervacc publicerar årsredovisning för 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-04 | Intervacc | Intervacc announces changes in the Nomination Committee | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-04 | Intervacc | Intervacc offentliggör förändringar i valberedningen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-28 | Intervacc | Jonas Sohlman ny VD för Intervacc AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-28 | Intervacc | Jonas Sohlman appointed as new CEO for Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-22 | Intervacc | Intervacc announces changes in dates for AGM and report for the first quarter 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-22 | Intervacc | Intervacc tidigarelägger årsstämma och rapport för första kvartalet 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-21 | Penser Access by Carnegie | Penser Access by Carnegie: Intervacc - Behöver visa tillväxt | Pressreleaser | Visa Stäng |
|
||||
2024-02-16 | Intervacc | Intervacc: Year-end report January - December 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-16 | Intervacc | Intervacc: Bokslutskommuniké januari - december 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-13 | Intervacc | Intervacc: Inbjudan till telefonkonferens och audiocast i samband med bokslutskommuniké | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-13 | Intervacc | Intervacc: Invitation to conference call and audiocast in connection with the year-end report | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-07 | Intervacc | Intervacc awarded prestigious Eurostars grant to advance their new prototype vaccine against Streptococcus suis infection in pigs | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-07 | Intervacc | Intervaccs tilldelas prestigefullt bidrag från Eurostars för vidareutveckling av sitt prototypvaccin till gris | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-21 | Intervacc | Intervacc announces changes in the Nomination Committee | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-21 | Intervacc | Förändringar av valberedningen i Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-11 | Intervacc | Intervacc: The National Equestrian Centre at Flyinge to host European expert meeting on the use of vaccination to prevent strangles in horses | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-11 | Intervacc | Intervacc: Europas ledande experter inom kvarka träffas vid riksanläggningen i Flyinge för att dela de senaste framstegen kring smittskydd och vaccination | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-23 | Intervacc | Kommuniké från extra bolagsstämma i Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-23 | Intervacc | Report from Extraordinary General Meeting in Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-22 | Intervacc | U.S. patent approval for Intervacc's vaccine against infections caused by Streptococcus suis | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-22 | Intervacc | Intervacc beviljas patent i USA för vaccin mot infektioner orsakade av Streptococcus suis | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-17 | Penser Access | Penser Access: IVACC Q3 2023 - Intervacc | Pressreleaser | Visa Stäng |
|
||||
2023-11-16 | Intervacc | Intervacc: Delårsrapport januari - september 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-11-16 | Intervacc | Intervacc: Interim report January - September 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-11-15 | Intervacc | Inbjudan till webcast i samband med Intervaccs delårsrapport för tredje kvartalet, 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-15 | Intervacc | Invitation to conference call with presentation of Intervacc's Interim report for the third quarter, 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-30 | Intervacc | Valberedning utsedd i Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-30 | Intervacc | Nomination Committee appointed in Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-19 | Intervacc | Intervacc: NOTICE OF EXTRAORDINARY GENERAL MEETING IN INTERVACC AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-19 | Intervacc | Intervacc: KALLELSE TILL EXTRA BOLAGSSTÄMMA I INTERVACC AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-01 | Penser Access | Penser Access: IVACC Q2’23 - Intervacc | Pressreleaser | Visa Stäng |
|
||||
2023-08-31 | Intervacc | Intervacc: Delårsrapport januari - juni 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-31 | Intervacc | Intervacc: Interim report January - June 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-21 | Intervacc | Andreas Andersson steps down as President and CEO. Jonas Sohlman has been appointed acting President and CEO for Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-21 | Intervacc | Andreas Andersson slutar som VD och koncernchef - Jonas Sohlman har utsetts som tillförordnad VD och koncernchef för Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-17 | Intervacc | Intervacc beviljas bidrag för att utveckla tillverkningsprocessen för ett prototypvaccin för grisar | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-17 | Intervacc | Intervacc awarded grant to optimise production processes for a fusion protein, which is one component of a prototype vaccine for pigs | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-11 | Intervacc | Intervacc to collaborate with Testa Center to optimise production processes for their prototype vaccine for pigs | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-11 | Intervacc | Intervaccs beviljas medel för uppstartsfasen i ett utvecklingsprojekt som avser att ta fram tillverkningsprocesser för ett prototypvaccin mot Streptococcus suis infektioner hos gris | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-10 | Intervacc | Intervacc ställer ut på Falsterbo Horse Show | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-08 | Intervacc | Intervacc offentliggör utfall i den fullt säkerställda företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-08 | Intervacc | Intervacc announces the outcome of the fully secured rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-07 | Intervacc | Kommuniké från årsstämman i Intervacc AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-07 | Intervacc | Report from Annual General Meeting in Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-22 | Intervacc | Intervacc AB (publ) publishes prospectus in connection with a fully covered rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-22 | Intervacc | Intervacc AB (publ) offentliggör prospekt i samband med fullt säkerställd företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-17 | Intervacc | Intervacc: Europeiska läkemedelsmyndigheten (EMA) godkänner förlängning av hållbarheten för Strangvac, ett vaccin mot kvarka, till 33 månader | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-17 | Intervacc | Intervacc: The European Medicines Agency (EMA) approves extention of shelf life for Strangvac, a vaccine against equine strangles, to 33 months | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-15 | Penser Access | Penser Access: Villkoren för företrädesemissionen kommunicerade - Intervacc | Pressreleaser | Visa Stäng |
|
||||
2023-05-11 | Intervacc | Styrelsen i Intervacc har beslutat om en fullt säkerställd företrädesemission om cirka 104 miljoner kronor | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-11 | Intervacc | The Board of Directors in Intervacc has resolved on a fully covered rights issue of approximately SEK 104 million | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-08 | Intervacc | Intervacc: Veterinary Medicines Directorate (VMD) extends the shelf life for Strangvac, a vaccine against equine strangles, to 33 months | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Intervacc: Veterinary Medicines Directorate (VMD) extends the shelf life for Strangvac, a vaccine against equine strangles, to 33 months”It is positive that the Veterinary Medicines Directorate (VMD) now has approved a 33-month shelf life for Strangvac. It provides us with increased flexibility in the logistics chain and facilitates the planning of our production”, comments Andreas Andersson, CEO of Intervacc. For more information please contact: Andreas Andersson, CEO Phone: +46-8-120 10 601, cell +46-73-335 99 70 The information was submitted for publication, through the agency of the contact person set out above on May 8, 2023, 15.00 CET. About Intervacc Intervacc AB is a Swedish company within animal health developing vaccines for animals. The Company’s vaccine and vaccine candidates are based on several years of research at Karolinska Institutet and Swedish University of Agricultural Research where the foundation was laid for the Company’s research and development work. The technology platform is based on fusion proteins produced using recombinant DNA technology. The Intervacc share has been listed on the Nasdaq First North Growth Market since April 2017 with Eminova Fondkommission AB as Certified Adviser. About equine strangles Equine strangles is a severe, common, and highly contagious horse disease where the horse develops fever, nasal discharge, cough, and sometimes large abscesses in the lymph nodes of the head and neck. Equine strangles is caused by the streptococcus bacteria Streptococcus equi. The onset of the disease can range from mild cold-like symptoms to severe abscesses in the throat that can burst, leading to breathing difficulties. The mortality rate is up to 10 percent in infected herds, but more typically around 2 percent. Equine strangles can also cause secondary infections such as pneumonia or abscesses in other parts of the body. It affects horses worldwide, except for Iceland where the import of horses is prohibited. Some of the horses that recover from strangles remain persistently infected. These silent carriers are perceived by others as completely healthy animals, but they spread the bacteria to the environment and to other horses with which they come into contact. Outbreaks of equine strangles often have significant consequences for horse owners, as isolation, closure, and other measures are required. The Swedish National Veterinary Institute (SVA) recommends isolating all horses on the premises, both sick and asymptomatic, for four to six weeks from the day of the last symptoms observed in the last affected horse. About Strangvac Strangvac is approved for sale and marketing in the EU as well as the UK and Norway. Strangvac has been launched in Sweden, Denmark, the UK, France, Germany, the Benelux region, Austria, Ireland, Poland and Italy. Strangvac is administered intramuscularly and does not contain any live or attenuated S. equi bacteria or S. equi DNA. Strangvac does not contain any of the antigens used in serological tests for equine strangles and therefore does not yield positive results in these tests. This means that vaccinated horses can be distinguished from those who have or have had the infection. Contact information for Certified Adviser Eminova Fondkommission AB E-mail: |
||||
2023-05-08 | Intervacc | Intervacc: Veterinary Medicines Directorate (VMD) förlänger hållbarheten för Strangvac, ett vaccin mot kvarka, till 33 månader i Storbritannien | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-05 | Intervacc | Intervacc: CORRECTION: NOTICE OF ANNUAL GENERAL MEETING IN INTERVACC AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-05 | Intervacc | Intervacc: RÄTTELSE: KALLELSE TILL ÅRSSTÄMMA I INTERVACC AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-05 | Intervacc | Intervacc: KALLELSE TILL ÅRSSTÄMMA I INTERVACC AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-05 | Intervacc | Intervacc: NOTICE OF ANNUAL GENERAL MEETING IN INTERVACC AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-05 | Intervacc | Report from Extraordinary General Meeting in Intervacc | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-05 | Intervacc | Kommuniké från extra bolagsstämma i Intervacc AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-04 | Penser Access | Penser Access: Försäljningsstarten tar längre tid än väntat - Intervacc | Pressreleaser | Visa Stäng |
|
||||
2023-05-03 | Intervacc | Intervacc: Interim report January - March 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-03 | Intervacc | Intervacc: Delårsrapport januari - mars 2023 | Rapporter | Ladda ner | Visa Stäng |
|